Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | NPC1 | O15118 | 10/20 | 0.65 |
| ▸ | RAB9A | P51151 | 9/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.65 |
| ▸ | PKM | P14618 | 2/20 | 0.65 |
| ▸ | MITF | O75030 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | STAT3 | P40763 | 1/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | GAPDH | P04406 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16011604 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16899277 | 0.81 | NPC1 (0.79) | ALDH1A1TSHRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL27711484 | 0.81 | TSHR (1.00) | ALDH1A1TSHRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL28470273 | 0.81 | NPC1 (0.55) | ALDH1A1TSHRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL2438512 | 0.78 | NPC1 (0.57) | TSHRNPC1RAB9ASMN1; SMN2PKM | |
| SCHEMBL1844028 | 0.77 | NPC1 (0.60) | NPC1RAB9ASMN1; SMN2PKMMITF | |
| SCHEMBL23965986 | 0.77 | L3MBTL1 (0.68) | ALDH1A1TSHRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3407320 | 0.77 | RAB9A (0.76) | ALDH1A1TSHRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL30354808 | 0.77 | MEN1 (0.65) | ALDH1A1TSHRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL25383237 | 0.77 | MEN1 (0.65) | ALDH1A1TSHRNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10464929-B2 | Organic molecules for terahertz tagging applications | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2019-11-05 | — | — | US | claimed |
| EP-3094621-A1 | ORGANIC MOLECULES FOR TERAHERTZ TAGGING APPLICATIONS | Council of Scientific & Industrial Research (IN) | 2016-11-23 | — | — | EP | claimed |
| US-20160335827-A1 | ORGANIC MOLECULES FOR TERAHERTZ TAGGING APPLICATIONS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-11-17 | — | — | US | claimed |
| WO-2015104722-A1 | ORGANIC MOLECULES FOR TERAHERTZ TAGGING APPLICATIONS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-07-16 | — | — | WO | claimed |
| JP-4828407-B2 | — | — | 2011-11-30 | — | — | JP | claimed |
| EP-1594869-A2 | 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF | Targacept, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| WO-2004076449-A2 | 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF | TARGACEPT, INC. (US) | 2004-09-10 | — | — | WO | claimed |
| WO-2025151311-A1 | NICOTINAMIDE DERIVATIVES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-07-17 | — | — | WO | disclosed |
| CN-109053558-B | Synthesis method of N-heterocyclic amide derivative | 贵州大学 | 2022-02-18 | — | — | CN | disclosed |
| CN-113735850-A | Synthesis method of 1,2, 4-triazole compound | 河南师范大学 | 2021-12-03 | — | — | CN | disclosed |
| EP-3392240-B1 | USE OF N-(PYRIDIN-2-YL)-AMIDE AND PHENYL-UREA DERIVATIVES FOR TERAHERTZ TAGGING APPLICATIONS | COUNCIL SCIENT IND RES (IN) | 2020-06-03 | — | — | EP | disclosed |
| EP-3392240-B1 | USE OF N-(PYRIDIN-2-YL)-AMIDE AND PHENYL-UREA DERIVATIVES FOR TERAHERTZ TAGGING APPLICATIONS | COUNCIL SCIENT IND RES (IN) | 2020-06-03 | — | — | EP | disclosed |
| US-10464929-B2 | Organic molecules for terahertz tagging applications | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2019-11-05 | — | — | US | disclosed |
| US-8106051-B2 | 4-Chloro-N-(4-tolyl)benzamide; to enhance the serum level of apoAI | SHIONOGI & CO., LTD. (JP) | 2012-01-31 | — | — | US | disclosed |
| US-7429593-B2 | Utilities of amide compounds | SHIONOGI & CO., LTD. (JP) | 2008-09-30 | — | — | US | disclosed |
| US-7429593-B2 | Utilities of amide compounds | SHIONOGI & CO., LTD. (JP) | 2008-09-30 | — | — | US | disclosed |
| US-20080221112-A1 | 4-Chloro-N-(4-tolyl)benzamide; to enhance the serum level of apoAI | YAMAMORI TERUO | 2008-09-11 | — | — | US | disclosed |
| US-20080221112-A1 | 4-Chloro-N-(4-tolyl)benzamide; to enhance the serum level of apoAI | YAMAMORI TERUO | 2008-09-11 | — | — | US | disclosed |
| EP-1453828-A2 | AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME | AstraZeneca AB (SE) | 2004-09-08 | — | — | EP | disclosed |
| WO-2003032897-A2 | AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME | ASTRAZENECA AB (SE) | 2003-04-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160335827-A1 | ORGANIC MOLECULES FOR TERAHERTZ TAGGING APPLICATIONS | WIZ, CRYZ, NAA15 | ALDH1A1 978/4885TSHR 2793/4885NPC1 4342/4885 |
| US-20080221112-A1 | 4-Chloro-N-(4-tolyl)benzamide; to enhance the serum level of apoAI | APOL1, PON1, APOB | ALDH1A1 1284/4885TSHR 2036/4885NPC1 226/4885 |
| US-10464929-B2 | Organic molecules for terahertz tagging applications | WIZ, CRYZ, NAA15 | ALDH1A1 978/4885TSHR 2793/4885NPC1 4342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.